IDDF2018-ABS-0114 SOF/VEL/VOX results in high SVR12 rates when administered for 12 weeks in DAA-experienced patients or for 8 weeks in daa-naive patients: an integrated analysis of the polaris-1, polaris-2, polaris-3 and polaris-4 studiesStuart K Roberts,Curtis L Cooper,Eric Lawitz,K Rajender Reddy,Alex J Thompson,Stefan Zeuzem,Ira M Jacobson,Peter Ruane,Robert H Hyland,Luisa M Stamm,Lingling Han,Diana M Brainard, Christina Sm Yip, HC Huang,Norbert Brau,Tarik Asselah,Bernard E Willems,Steven Flamm,Marc Bourliere,Graham R Foster,Edward J Gane,Michael Manns,Stuart C Gordon,Kris KowdleyGut（2018）引用 1|浏览40暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
